Kornitzer Capital Management Inc Adma Biologics, Inc. Transaction History
Kornitzer Capital Management Inc
- $4.65 Billion
- Q1 2025
A detailed history of Kornitzer Capital Management Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 47,870 shares of ADMA stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
47,870
Previous 33,000
45.06%
Holding current value
$1.13 Million
Previous $565,000
67.96%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
354Shares Held
183MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$442 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$431 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$353 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$268 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$131 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.66B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...